These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
570 related articles for article (PubMed ID: 16584978)
1. Nuclear envelope proteins and chromatin arrangement: a pathogenic mechanism for laminopathies. Maraldi NM; Lattanzi G; Capanni C; Columbaro M; Merlini L; Mattioli E; Sabatelli P; Squarzoni S; Manzoli FA Eur J Histochem; 2006; 50(1):1-8. PubMed ID: 16584978 [TBL] [Abstract][Full Text] [Related]
2. Effect of pathogenic mis-sense mutations in lamin A on its interaction with emerin in vivo. Holt I; Ostlund C; Stewart CL; Man Nt; Worman HJ; Morris GE J Cell Sci; 2003 Jul; 116(Pt 14):3027-35. PubMed ID: 12783988 [TBL] [Abstract][Full Text] [Related]
3. Both lamin A and lamin C mutations cause lamina instability as well as loss of internal nuclear lamin organization. Broers JL; Kuijpers HJ; Ostlund C; Worman HJ; Endert J; Ramaekers FC Exp Cell Res; 2005 Apr; 304(2):582-92. PubMed ID: 15748902 [TBL] [Abstract][Full Text] [Related]
4. Lamin A/C assembly defects in Emery-Dreifuss muscular dystrophy can be regulated by culture medium composition. Holt I; Nguyen TM; Wehnert M; Morris GE Neuromuscul Disord; 2006 Jun; 16(6):368-73. PubMed ID: 16697197 [TBL] [Abstract][Full Text] [Related]
5. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. Bakay M; Wang Z; Melcon G; Schiltz L; Xuan J; Zhao P; Sartorelli V; Seo J; Pegoraro E; Angelini C; Shneiderman B; Escolar D; Chen YW; Winokur ST; Pachman LM; Fan C; Mandler R; Nevo Y; Gordon E; Zhu Y; Dong Y; Wang Y; Hoffman EP Brain; 2006 Apr; 129(Pt 4):996-1013. PubMed ID: 16478798 [TBL] [Abstract][Full Text] [Related]
6. How does a g993t mutation in the emerin gene cause Emery-Dreifuss muscular dystrophy? Holt I; Clements L; Manilal S; Morris GE Biochem Biophys Res Commun; 2001 Oct; 287(5):1129-33. PubMed ID: 11587540 [TBL] [Abstract][Full Text] [Related]
7. Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy. Cenni V; Sabatelli P; Mattioli E; Marmiroli S; Capanni C; Ognibene A; Squarzoni S; Maraldi NM; Bonne G; Columbaro M; Merlini L; Lattanzi G J Med Genet; 2005 Mar; 42(3):214-20. PubMed ID: 15744034 [TBL] [Abstract][Full Text] [Related]
8. Immunocytochemistry of nuclear domains and Emery-Dreifuss muscular dystrophy pathophysiology. Maraldi NM; Lattanzi G; Sabatelli P; Ognibene A; Columbaro M; Capanni C; Rutigliano C; Mattioli E; Squarzoni S Eur J Histochem; 2003; 47(1):3-16. PubMed ID: 12685553 [TBL] [Abstract][Full Text] [Related]
10. The R482Q lamin A/C mutation that causes lipodystrophy does not prevent nuclear targeting of lamin A in adipocytes or its interaction with emerin. Holt I; Clements L; Manilal S; Brown SC; Morris GE Eur J Hum Genet; 2001 Mar; 9(3):204-8. PubMed ID: 11313760 [TBL] [Abstract][Full Text] [Related]
11. Lamins A and C are differentially dysfunctional in autosomal dominant Emery-Dreifuss muscular dystrophy. Motsch I; Kaluarachchi M; Emerson LJ; Brown CA; Brown SC; Dabauvalle MC; Ellis JA Eur J Cell Biol; 2005 Sep; 84(9):765-81. PubMed ID: 16218190 [TBL] [Abstract][Full Text] [Related]
12. Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity. Zhang Q; Bethmann C; Worth NF; Davies JD; Wasner C; Feuer A; Ragnauth CD; Yi Q; Mellad JA; Warren DT; Wheeler MA; Ellis JA; Skepper JN; Vorgerd M; Schlotter-Weigel B; Weissberg PL; Roberts RG; Wehnert M; Shanahan CM Hum Mol Genet; 2007 Dec; 16(23):2816-33. PubMed ID: 17761684 [TBL] [Abstract][Full Text] [Related]